Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Anti-Ige-antikörper (omalizumab). Therapieindikation in der pädiatrie
Translated title of the contribution
:
Anti-IgE-antibody (omalizumab). Indication for treatment in pediatrics
M. V. Kopp
*
, J. Kühr
*
Corresponding author for this work
Clinic of Pediatric and Adolescent Medicine
Städtisches Klinikum Karlsruhe
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Anti-IgE-antibody (omalizumab). Indication for treatment in pediatrics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
Immunoglobulin E Antibody
100%
Immunoglobulin E
100%
Food Allergy
33%
Allergic Rhinitis
33%
Asthma Exacerbation
33%
Monoclonal Anti-IgE
33%
Medicine and Dentistry
Disease Process
66%
Patient
33%
Child
33%
Adult
33%
Medication
33%
Provocation Test
33%
Pharmacology, Toxicology and Pharmaceutical Science
Medication
33%